CLINICAL_TRIALS
trial_result
· 2016-03-07
Clinical Trial Update: A Study of Dulaglutide in Chinese Participants [Phase 1]
Summary
Phase 1 trial of dulaglutide in Chinese participants completed, with results posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type 2, Healthy Volunteers | Phase 1 | Status: COMPLETED | Results posted: 2016-03-07